1. United Kingdom Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Shield Therapeutics Plc

Shield Therapeutics Plc

5.42
GBX
-0.18
(-3.21%)
6.63BMarket Cap
Apr 29Next Earn

Latest Stock Split

Dec 16, 2022

35:34

For every 34 shares held, investors received 35. The price per share adjusted from $7.00 to $6.80.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Dec 16, 2022
    Before$7.00
    Split ratio35:34
    After$6.80
    Forward
  2. Mar 01, 2021
    Before$41.00
    Split ratio779:757
    After$39.84
    Forward

About Shield Therapeutics Plc stock splits

Shield Therapeutics Plc (LSE:STX) operates in the Pharmaceuticals: major industry.

Shield Therapeutics Plc company overview

When did Shield Therapeutics Plc stock split?

Shield Therapeutics Plc's most recent stock split was on December 16, 2022. It was a 35-for-34 forward split, so shareholders received 35 shares for every 34 they held.

What is Shield Therapeutics Plc's stock split history?

Shield Therapeutics Plc (LSE:STX) has split its stock 2 times: a 779-for-757 split on March 1, 2021 and a 35-for-34 split on December 16, 2022.

How many times has Shield Therapeutics Plc stock split?

Shield Therapeutics Plc has split its stock 2 times. This history records 2 forward splits between March 1, 2021 and December 16, 2022.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Shield Therapeutics Plc's 35-for-34 split on December 16, 2022, every 34 shares became 35 shares.

Will Shield Therapeutics Plc split its stock again?

Shield Therapeutics Plc has not announced a new split in our records. Its most recent split was on December 16, 2022, 3 years ago. Companies announce splits in advance, and any new LSE:STX split will appear on this page.